

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 8.79148687 |
| 2 | DNA deamination (GO:0045006) | 7.13202515 |
| 3 | viral transcription (GO:0019083) | 6.48521902 |
| 4 | translational termination (GO:0006415) | 6.18754551 |
| 5 | ribosomal small subunit biogenesis (GO:0042274) | 5.59812337 |
| 6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.39338341 |
| 7 | translational elongation (GO:0006414) | 5.38802135 |
| 8 | platelet dense granule organization (GO:0060155) | 5.26625590 |
| 9 | cotranslational protein targeting to membrane (GO:0006613) | 5.24678309 |
| 10 | protein targeting to ER (GO:0045047) | 5.23416426 |
| 11 | definitive hemopoiesis (GO:0060216) | 5.08890696 |
| 12 | protein localization to endoplasmic reticulum (GO:0070972) | 5.01411913 |
| 13 | maturation of SSU-rRNA (GO:0030490) | 4.99577412 |
| 14 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.99320211 |
| 15 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.72864693 |
| 16 | viral life cycle (GO:0019058) | 4.71908637 |
| 17 | cellular protein complex disassembly (GO:0043624) | 4.62610243 |
| 18 | translational initiation (GO:0006413) | 4.35652490 |
| 19 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.34687763 |
| 20 | response to interferon-beta (GO:0035456) | 4.20591610 |
| 21 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.17469092 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 4.08694790 |
| 23 | protein complex disassembly (GO:0043241) | 4.02547013 |
| 24 | cytidine deamination (GO:0009972) | 3.91538336 |
| 25 | cytidine metabolic process (GO:0046087) | 3.91538336 |
| 26 | cytidine catabolic process (GO:0006216) | 3.91538336 |
| 27 | macromolecular complex disassembly (GO:0032984) | 3.77664024 |
| 28 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.75475770 |
| 29 | endothelium development (GO:0003158) | 3.75172917 |
| 30 | ribosomal large subunit biogenesis (GO:0042273) | 3.67728834 |
| 31 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.64283297 |
| 32 | DNA strand elongation (GO:0022616) | 3.63360992 |
| 33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.63166715 |
| 34 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.62393806 |
| 35 | telomere maintenance via recombination (GO:0000722) | 3.58560927 |
| 36 | iron-sulfur cluster assembly (GO:0016226) | 3.53175127 |
| 37 | metallo-sulfur cluster assembly (GO:0031163) | 3.53175127 |
| 38 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.53065345 |
| 39 | secretory granule organization (GO:0033363) | 3.50275795 |
| 40 | mRNA catabolic process (GO:0006402) | 3.47893914 |
| 41 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.47454549 |
| 42 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.47428113 |
| 43 | translation (GO:0006412) | 3.46834704 |
| 44 | respiratory chain complex IV assembly (GO:0008535) | 3.45994352 |
| 45 | proteasome assembly (GO:0043248) | 3.45784377 |
| 46 | pseudouridine synthesis (GO:0001522) | 3.43986036 |
| 47 | megakaryocyte development (GO:0035855) | 3.42100942 |
| 48 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.41967383 |
| 49 | erythrocyte maturation (GO:0043249) | 3.40251507 |
| 50 | protein targeting to membrane (GO:0006612) | 3.39373138 |
| 51 | daunorubicin metabolic process (GO:0044597) | 3.37934834 |
| 52 | polyketide metabolic process (GO:0030638) | 3.37934834 |
| 53 | doxorubicin metabolic process (GO:0044598) | 3.37934834 |
| 54 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.37284892 |
| 55 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.35063840 |
| 56 | heme biosynthetic process (GO:0006783) | 3.29893491 |
| 57 | RNA catabolic process (GO:0006401) | 3.29602179 |
| 58 | DNA replication initiation (GO:0006270) | 3.29519872 |
| 59 | regulation of antigen processing and presentation (GO:0002577) | 3.25526152 |
| 60 | type I interferon signaling pathway (GO:0060337) | 3.24280420 |
| 61 | cellular response to type I interferon (GO:0071357) | 3.24280420 |
| 62 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.22310206 |
| 63 | response to type I interferon (GO:0034340) | 3.20988251 |
| 64 | telomere maintenance via telomere lengthening (GO:0010833) | 3.19287164 |
| 65 | embryonic hemopoiesis (GO:0035162) | 3.16413094 |
| 66 | regulation of erythrocyte differentiation (GO:0045646) | 3.15138726 |
| 67 | B cell mediated immunity (GO:0019724) | 3.12393837 |
| 68 | response to interferon-alpha (GO:0035455) | 3.11826225 |
| 69 | cellular response to interferon-beta (GO:0035458) | 3.11577470 |
| 70 | mature B cell differentiation involved in immune response (GO:0002313) | 3.08677608 |
| 71 | purine-containing compound salvage (GO:0043101) | 3.07290703 |
| 72 | mitotic recombination (GO:0006312) | 3.06689904 |
| 73 | positive regulation of granulocyte differentiation (GO:0030854) | 3.06074645 |
| 74 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.05414917 |
| 75 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.05304228 |
| 76 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.05304228 |
| 77 | blood vessel maturation (GO:0001955) | 3.04028602 |
| 78 | positive regulation of antigen processing and presentation (GO:0002579) | 3.02178306 |
| 79 | positive thymic T cell selection (GO:0045059) | 3.01082562 |
| 80 | cellular component biogenesis (GO:0044085) | 2.99599431 |
| 81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.98784306 |
| 82 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.98472817 |
| 83 | membrane raft organization (GO:0031579) | 2.94574303 |
| 84 | neutrophil activation involved in immune response (GO:0002283) | 2.93193808 |
| 85 | phospholipid scrambling (GO:0017121) | 2.93018015 |
| 86 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.92414843 |
| 87 | angiogenesis involved in wound healing (GO:0060055) | 2.91166035 |
| 88 | CENP-A containing nucleosome assembly (GO:0034080) | 2.89802742 |
| 89 | cytochrome complex assembly (GO:0017004) | 2.89725889 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 2.88899000 |
| 91 | regulation of T cell tolerance induction (GO:0002664) | 2.88659628 |
| 92 | negative regulation of cell killing (GO:0031342) | 2.88255197 |
| 93 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.88255197 |
| 94 | rRNA processing (GO:0006364) | 2.88225760 |
| 95 | granulocyte differentiation (GO:0030851) | 2.87669544 |
| 96 | oxidative phosphorylation (GO:0006119) | 2.86888378 |
| 97 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.85569212 |
| 98 | heme metabolic process (GO:0042168) | 2.83479368 |
| 99 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.82447824 |
| 100 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.81683052 |
| 101 | endosome to melanosome transport (GO:0035646) | 2.79721472 |
| 102 | endosome to pigment granule transport (GO:0043485) | 2.79721472 |
| 103 | rRNA metabolic process (GO:0016072) | 2.77154345 |
| 104 | aerobic respiration (GO:0009060) | 2.77071938 |
| 105 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.76505282 |
| 106 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.72662422 |
| 107 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.72662422 |
| 108 | NADH dehydrogenase complex assembly (GO:0010257) | 2.72662422 |
| 109 | lymphoid progenitor cell differentiation (GO:0002320) | 2.70658792 |
| 110 | detection of bacterium (GO:0016045) | 2.70497510 |
| 111 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.69769723 |
| 112 | chromatin remodeling at centromere (GO:0031055) | 2.69104250 |
| 113 | tRNA methylation (GO:0030488) | 2.68190400 |
| 114 | detection of other organism (GO:0098543) | 2.67450146 |
| 115 | regulation of interleukin-8 secretion (GO:2000482) | 2.66941868 |
| 116 | regulation of metalloenzyme activity (GO:0048552) | 2.65629113 |
| 117 | formation of translation preinitiation complex (GO:0001731) | 2.65312500 |
| 118 | negative regulation of viral genome replication (GO:0045071) | 2.65270640 |
| 119 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.64924987 |
| 120 | regulation of regulatory T cell differentiation (GO:0045589) | 2.64447455 |
| 121 | regulation of macrophage chemotaxis (GO:0010758) | 2.62974640 |
| 122 | regulation of skeletal muscle contraction (GO:0014819) | 2.61869742 |
| 123 | protein complex biogenesis (GO:0070271) | 2.61816951 |
| 124 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.61784381 |
| 125 | heart contraction (GO:0060047) | 2.60855223 |
| 126 | heart process (GO:0003015) | 2.60855223 |
| 127 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.59719748 |
| 128 | T cell homeostasis (GO:0043029) | 2.59203022 |
| 129 | ribosome biogenesis (GO:0042254) | 2.58265202 |
| 130 | termination of RNA polymerase III transcription (GO:0006386) | 2.57614927 |
| 131 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.57614927 |
| 132 | negative regulation of interleukin-12 production (GO:0032695) | 2.57034886 |
| 133 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.57021838 |
| 134 | T cell migration (GO:0072678) | 2.56944346 |
| 135 | regulation of tolerance induction (GO:0002643) | 2.56436870 |
| 136 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.54443729 |
| 137 | lymphocyte chemotaxis (GO:0048247) | 2.54011309 |
| 138 | negative regulation of bone mineralization (GO:0030502) | 2.53910811 |
| 139 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.53908616 |
| 140 | viral mRNA export from host cell nucleus (GO:0046784) | 2.53766633 |
| 141 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.51169578 |
| 142 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.50186369 |
| 143 | negative regulation of monooxygenase activity (GO:0032769) | 2.49695477 |
| 144 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.48331870 |
| 145 | positive regulation of respiratory burst (GO:0060267) | 2.48112325 |
| 146 | erythrocyte development (GO:0048821) | 2.47787784 |
| 147 | positive regulation of tolerance induction (GO:0002645) | 2.47761424 |
| 148 | cellular response to interferon-gamma (GO:0071346) | 2.46599971 |
| 149 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.46227886 |
| 150 | phagocytosis, engulfment (GO:0006911) | 2.45323412 |
| 151 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.45157515 |
| 152 | negative regulation of innate immune response (GO:0045824) | 2.44991045 |
| 153 | positive regulation by symbiont of host defense response (GO:0052509) | 2.44503493 |
| 154 | modulation by symbiont of host defense response (GO:0052031) | 2.44503493 |
| 155 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.44503493 |
| 156 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.44503493 |
| 157 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.44503493 |
| 158 | modulation by symbiont of host immune response (GO:0052553) | 2.44503493 |
| 159 | tRNA modification (GO:0006400) | 2.43807470 |
| 160 | regulation of necrotic cell death (GO:0010939) | 2.42990578 |
| 161 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.42359233 |
| 162 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.42120187 |
| 163 | microglial cell activation (GO:0001774) | 2.41883373 |
| 164 | response to interferon-gamma (GO:0034341) | 2.41391718 |
| 165 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.41215588 |
| 166 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.41096719 |
| 167 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.41021200 |
| 168 | positive regulation of type 2 immune response (GO:0002830) | 2.40875082 |
| 169 | actin nucleation (GO:0045010) | 2.40566571 |
| 170 | regulation of gamma-delta T cell activation (GO:0046643) | 2.38844930 |
| 171 | regulation of interleukin-1 secretion (GO:0050704) | 2.38395526 |
| 172 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.38160497 |
| 173 | regulation of mononuclear cell migration (GO:0071675) | 2.37413285 |
| 174 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.36764253 |
| 175 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.35899835 |
| 176 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.33119142 |
| 177 | regulation of T cell migration (GO:2000404) | 2.32925436 |
| 178 | negative regulation of stress fiber assembly (GO:0051497) | 2.32760660 |
| 179 | negative T cell selection (GO:0043383) | 2.30063917 |
| 180 | regulation of type 2 immune response (GO:0002828) | 2.29053054 |
| 181 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.28758998 |
| 182 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.28393380 |
| 183 | positive regulation of defense response to virus by host (GO:0002230) | 2.27568464 |
| 184 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.26859980 |
| 185 | actin-myosin filament sliding (GO:0033275) | 2.26512247 |
| 186 | muscle filament sliding (GO:0030049) | 2.26512247 |
| 187 | positive T cell selection (GO:0043368) | 2.26279365 |
| 188 | T cell costimulation (GO:0031295) | 2.26170390 |
| 189 | positive regulation of interleukin-1 production (GO:0032732) | 2.25910888 |
| 190 | positive regulation of lymphocyte migration (GO:2000403) | 2.24763254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.99223434 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.04767275 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.75773895 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.72904397 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.55506975 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.26781654 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.14920648 |
| 8 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.02674189 |
| 9 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.93494980 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.73935269 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.70784486 |
| 12 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.62589996 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.60992592 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.60090539 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.54326698 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.48081607 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.47193243 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45789323 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.44970415 |
| 20 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.43890701 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.42426460 |
| 22 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.41849305 |
| 23 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.38375435 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.36847160 |
| 25 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.31987743 |
| 26 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.28459761 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.24080238 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.18006891 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.17261011 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.14359395 |
| 31 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.12231989 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.12149013 |
| 33 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.12074225 |
| 34 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09899612 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.09787420 |
| 36 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.08293799 |
| 37 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.06629561 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.06547528 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.05542774 |
| 40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.01282097 |
| 41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.00936241 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.99764918 |
| 43 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94753748 |
| 44 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.91972912 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.91653054 |
| 46 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.89312690 |
| 47 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.89283793 |
| 48 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.88893484 |
| 49 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.84452689 |
| 50 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.79288802 |
| 51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.78876776 |
| 52 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.77617023 |
| 53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75909277 |
| 54 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.75784033 |
| 55 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74591266 |
| 56 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.72899853 |
| 57 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.69726358 |
| 58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68549803 |
| 59 | MYC_22102868_ChIP-Seq_BL_Human | 1.67540335 |
| 60 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.65187415 |
| 61 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.65062170 |
| 62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63919055 |
| 63 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.63590452 |
| 64 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.57642909 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.54568473 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54295052 |
| 67 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.53267652 |
| 68 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.52467132 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.52260858 |
| 70 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.51214537 |
| 71 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.51150389 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48822166 |
| 73 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.47995051 |
| 74 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.47346601 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46533603 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46130884 |
| 77 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.45993729 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.42744317 |
| 79 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42597619 |
| 80 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39545026 |
| 81 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39122272 |
| 82 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.37784221 |
| 83 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37345403 |
| 84 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.36071539 |
| 85 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33723822 |
| 86 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32823316 |
| 87 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.30475105 |
| 88 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30322530 |
| 89 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27972274 |
| 90 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.26736849 |
| 91 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.24300082 |
| 92 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22675824 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22550395 |
| 94 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.22414238 |
| 95 | MYB_26560356_Chip-Seq_TH2_Human | 1.21019327 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20723131 |
| 97 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18646162 |
| 98 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.17250742 |
| 99 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16964424 |
| 100 | MYB_26560356_Chip-Seq_TH1_Human | 1.16466234 |
| 101 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.14961134 |
| 102 | MAF_26560356_Chip-Seq_TH1_Human | 1.14762715 |
| 103 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.14695236 |
| 104 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.14650195 |
| 105 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.13419659 |
| 106 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.13398055 |
| 107 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.11727900 |
| 108 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11636916 |
| 109 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.11589726 |
| 110 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10598847 |
| 111 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09812400 |
| 112 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09195759 |
| 113 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.08203903 |
| 114 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07473681 |
| 115 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07448995 |
| 116 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06461546 |
| 117 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.05359190 |
| 118 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04884475 |
| 119 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.04551279 |
| 120 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.04149898 |
| 121 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03384607 |
| 122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.03253255 |
| 123 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03119574 |
| 124 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03034909 |
| 125 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.01745013 |
| 126 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01358652 |
| 127 | MAF_26560356_Chip-Seq_TH2_Human | 1.00753013 |
| 128 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99585800 |
| 129 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99186511 |
| 130 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98490642 |
| 131 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98209190 |
| 132 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.96396904 |
| 133 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96382140 |
| 134 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.94686572 |
| 135 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94314346 |
| 136 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94284446 |
| 137 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.94213463 |
| 138 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93874413 |
| 139 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93456597 |
| 140 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93336005 |
| 141 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.92682959 |
| 142 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92567677 |
| 143 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.91022139 |
| 144 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90497817 |
| 145 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.89953854 |
| 146 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89670196 |
| 147 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.89242271 |
| 148 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.88899978 |
| 149 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.88299908 |
| 150 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88267976 |
| 151 | SA1_27219007_Chip-Seq_Bcells_Human | 0.88132667 |
| 152 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86755177 |
| 153 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.86391685 |
| 154 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86373111 |
| 155 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86257220 |
| 156 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85993061 |
| 157 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85858858 |
| 158 | P300_27268052_Chip-Seq_Bcells_Human | 0.83822346 |
| 159 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.82025531 |
| 160 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81244229 |
| 161 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.79546538 |
| 162 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79422141 |
| 163 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.78658783 |
| 164 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78400924 |
| 165 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.78081747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 3.97296315 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.96823999 |
| 3 | MP0001545_abnormal_hematopoietic_system | 3.67642815 |
| 4 | MP0005397_hematopoietic_system_phenotyp | 3.67642815 |
| 5 | MP0006054_spinal_hemorrhage | 3.26827593 |
| 6 | MP0009379_abnormal_foot_pigmentation | 3.18809569 |
| 7 | MP0003656_abnormal_erythrocyte_physiolo | 3.17414955 |
| 8 | MP0003724_increased_susceptibility_to | 3.12909712 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.60288891 |
| 10 | MP0004808_abnormal_hematopoietic_stem | 2.58493926 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.45615494 |
| 12 | MP0003950_abnormal_plasma_membrane | 2.45291848 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.39709095 |
| 14 | MP0002132_abnormal_respiratory_system | 2.25855220 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.19946807 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.17473602 |
| 17 | MP0005671_abnormal_response_to | 2.14082443 |
| 18 | MP0005075_abnormal_melanosome_morpholog | 2.12870437 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.11018302 |
| 20 | MP0006082_CNS_inflammation | 2.06028043 |
| 21 | MP0000490_abnormal_crypts_of | 2.03074975 |
| 22 | MP0009785_altered_susceptibility_to | 2.00181785 |
| 23 | MP0000685_abnormal_immune_system | 1.97198141 |
| 24 | MP0001853_heart_inflammation | 1.96051253 |
| 25 | MP0003693_abnormal_embryo_hatching | 1.93288145 |
| 26 | MP0002398_abnormal_bone_marrow | 1.92662059 |
| 27 | MP0010094_abnormal_chromosome_stability | 1.91295502 |
| 28 | MP0000465_gastrointestinal_hemorrhage | 1.88496519 |
| 29 | MP0002933_joint_inflammation | 1.83657148 |
| 30 | MP0001542_abnormal_bone_strength | 1.83548008 |
| 31 | MP0005360_urolithiasis | 1.78776681 |
| 32 | MP0005503_abnormal_tendon_morphology | 1.78668477 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.75785935 |
| 34 | MP0008007_abnormal_cellular_replicative | 1.75026999 |
| 35 | MP0002095_abnormal_skin_pigmentation | 1.74880678 |
| 36 | MP0003186_abnormal_redox_activity | 1.71465842 |
| 37 | MP0001873_stomach_inflammation | 1.68718068 |
| 38 | MP0005025_abnormal_response_to | 1.63982949 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.63307637 |
| 40 | MP0003303_peritoneal_inflammation | 1.60068660 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.58549039 |
| 42 | MP0002722_abnormal_immune_system | 1.58191554 |
| 43 | MP0002429_abnormal_blood_cell | 1.51990912 |
| 44 | MP0001958_emphysema | 1.51707038 |
| 45 | MP0008058_abnormal_DNA_repair | 1.51535161 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.50462064 |
| 47 | MP0000749_muscle_degeneration | 1.50056348 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.49895761 |
| 49 | MP0001800_abnormal_humoral_immune | 1.49573143 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.49452922 |
| 51 | MP0009840_abnormal_foam_cell | 1.45110160 |
| 52 | MP0003075_altered_response_to | 1.44666893 |
| 53 | MP0002420_abnormal_adaptive_immunity | 1.43921499 |
| 54 | MP0004957_abnormal_blastocyst_morpholog | 1.41830020 |
| 55 | MP0002723_abnormal_immune_serum | 1.41653369 |
| 56 | MP0000716_abnormal_immune_system | 1.41590531 |
| 57 | MP0001819_abnormal_immune_cell | 1.40806894 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.38678953 |
| 59 | MP0010368_abnormal_lymphatic_system | 1.35846769 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.35575643 |
| 61 | MP0003077_abnormal_cell_cycle | 1.34894020 |
| 62 | MP0003111_abnormal_nucleus_morphology | 1.34390206 |
| 63 | MP0005275_abnormal_skin_tensile | 1.34160521 |
| 64 | MP0003646_muscle_fatigue | 1.34049856 |
| 65 | MP0000343_altered_response_to | 1.32926799 |
| 66 | MP0005165_increased_susceptibility_to | 1.32554657 |
| 67 | MP0005000_abnormal_immune_tolerance | 1.32224842 |
| 68 | MP0001986_abnormal_taste_sensitivity | 1.31484307 |
| 69 | MP0008057_abnormal_DNA_replication | 1.30962096 |
| 70 | MP0002148_abnormal_hypersensitivity_rea | 1.30526099 |
| 71 | MP0003448_altered_tumor_morphology | 1.30417939 |
| 72 | MP0004883_abnormal_blood_vessel | 1.27072664 |
| 73 | MP0001879_abnormal_lymphatic_vessel | 1.26918342 |
| 74 | MP0010155_abnormal_intestine_physiology | 1.25961842 |
| 75 | MP0004215_abnormal_myocardial_fiber | 1.23366334 |
| 76 | MP0002332_abnormal_exercise_endurance | 1.21632695 |
| 77 | MP0002419_abnormal_innate_immunity | 1.20091823 |
| 78 | MP0009697_abnormal_copulation | 1.18843666 |
| 79 | MP0005390_skeleton_phenotype | 1.18554372 |
| 80 | MP0000703_abnormal_thymus_morphology | 1.17600837 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 1.16821567 |
| 82 | MP0005595_abnormal_vascular_smooth | 1.16734026 |
| 83 | MP0009278_abnormal_bone_marrow | 1.15813541 |
| 84 | MP0002108_abnormal_muscle_morphology | 1.14841421 |
| 85 | MP0005164_abnormal_response_to | 1.14150138 |
| 86 | MP0003943_abnormal_hepatobiliary_system | 1.14044857 |
| 87 | MP0004036_abnormal_muscle_relaxation | 1.13905050 |
| 88 | MP0001188_hyperpigmentation | 1.13627476 |
| 89 | MP0002006_tumorigenesis | 1.12920215 |
| 90 | MP0003045_fibrosis | 1.12334490 |
| 91 | MP0000767_abnormal_smooth_muscle | 1.12069919 |
| 92 | MP0003786_premature_aging | 1.10902144 |
| 93 | MP0002405_respiratory_system_inflammati | 1.10692756 |
| 94 | MP0002295_abnormal_pulmonary_circulatio | 1.10460337 |
| 95 | MP0008469_abnormal_protein_level | 1.09673839 |
| 96 | MP0005166_decreased_susceptibility_to | 1.08559718 |
| 97 | MP0003828_pulmonary_edema | 1.08527752 |
| 98 | MP0000249_abnormal_blood_vessel | 1.08450501 |
| 99 | MP0006292_abnormal_olfactory_placode | 1.07369729 |
| 100 | MP0003436_decreased_susceptibility_to | 1.06249769 |
| 101 | MP0000750_abnormal_muscle_regeneration | 1.04187730 |
| 102 | MP0000372_irregular_coat_pigmentation | 1.02583681 |
| 103 | MP0001764_abnormal_homeostasis | 0.99932068 |
| 104 | MP0005023_abnormal_wound_healing | 0.99250169 |
| 105 | MP0000015_abnormal_ear_pigmentation | 0.98897617 |
| 106 | MP0002019_abnormal_tumor_incidence | 0.98377907 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.98192737 |
| 108 | MP0005409_darkened_coat_color | 0.96942592 |
| 109 | MP0000313_abnormal_cell_death | 0.94191007 |
| 110 | MP0009764_decreased_sensitivity_to | 0.90856377 |
| 111 | MP0003567_abnormal_fetal_cardiomyocyte | 0.90769012 |
| 112 | MP0003279_aneurysm | 0.90170400 |
| 113 | MP0003866_abnormal_defecation | 0.89641090 |
| 114 | MP0003705_abnormal_hypodermis_morpholog | 0.89405966 |
| 115 | MP0000759_abnormal_skeletal_muscle | 0.89401227 |
| 116 | MP0001845_abnormal_inflammatory_respons | 0.89297649 |
| 117 | MP0008775_abnormal_heart_ventricle | 0.89192284 |
| 118 | MP0004272_abnormal_basement_membrane | 0.89021577 |
| 119 | MP0005084_abnormal_gallbladder_morpholo | 0.88592622 |
| 120 | MP0003252_abnormal_bile_duct | 0.88156745 |
| 121 | MP0001790_abnormal_immune_system | 0.87818159 |
| 122 | MP0005387_immune_system_phenotype | 0.87818159 |
| 123 | MP0002998_abnormal_bone_remodeling | 0.87074023 |
| 124 | MP0005636_abnormal_mineral_homeostasis | 0.87052116 |
| 125 | MP0004510_myositis | 0.83480514 |
| 126 | MP0002139_abnormal_hepatobiliary_system | 0.82785228 |
| 127 | MP0000230_abnormal_systemic_arterial | 0.82135878 |
| 128 | MP0003011_delayed_dark_adaptation | 0.82055326 |
| 129 | MP0001663_abnormal_digestive_system | 0.80428618 |
| 130 | MP0000858_altered_metastatic_potential | 0.79559126 |
| 131 | MP0003300_gastrointestinal_ulcer | 0.79315228 |
| 132 | MP0005330_cardiomyopathy | 0.79170989 |
| 133 | MP0002938_white_spotting | 0.75581318 |
| 134 | MP0005319_abnormal_enzyme/_coenzyme | 0.69858599 |
| 135 | MP0009763_increased_sensitivity_to | 0.67762046 |
| 136 | MP0002877_abnormal_melanocyte_morpholog | 0.65158493 |
| 137 | MP0005167_abnormal_blood-brain_barrier | 0.64511517 |
| 138 | MP0006035_abnormal_mitochondrial_morpho | 0.63822311 |
| 139 | MP0000751_myopathy | 0.63018026 |
| 140 | MP0004084_abnormal_cardiac_muscle | 0.61485008 |
| 141 | MP0001533_abnormal_skeleton_physiology | 0.61393375 |
| 142 | MP0002075_abnormal_coat/hair_pigmentati | 0.60438834 |
| 143 | MP0000598_abnormal_liver_morphology | 0.59545785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 7.73788736 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 7.46645647 |
| 3 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 7.17620517 |
| 4 | Aplastic anemia (HP:0001915) | 5.22052536 |
| 5 | Reticulocytopenia (HP:0001896) | 4.94731033 |
| 6 | Petechiae (HP:0000967) | 4.82372910 |
| 7 | Prolonged bleeding time (HP:0003010) | 4.70704862 |
| 8 | Pallor (HP:0000980) | 4.29315746 |
| 9 | Popliteal pterygium (HP:0009756) | 4.07793312 |
| 10 | Nemaline bodies (HP:0003798) | 4.00311354 |
| 11 | Thrombocytosis (HP:0001894) | 3.88765462 |
| 12 | Amniotic constriction ring (HP:0009775) | 3.81705920 |
| 13 | Abnormality of placental membranes (HP:0011409) | 3.81705920 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.80701649 |
| 15 | Reduced antithrombin III activity (HP:0001976) | 3.58195901 |
| 16 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.51767593 |
| 17 | Muscle fiber inclusion bodies (HP:0100299) | 3.42600212 |
| 18 | Macrocytic anemia (HP:0001972) | 3.31996743 |
| 19 | Epistaxis (HP:0000421) | 3.31073954 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.30554037 |
| 21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.30554037 |
| 22 | Hepatocellular necrosis (HP:0001404) | 3.22920593 |
| 23 | Type I transferrin isoform profile (HP:0003642) | 3.21556982 |
| 24 | Abnormal platelet function (HP:0011869) | 3.20757832 |
| 25 | Impaired platelet aggregation (HP:0003540) | 3.20757832 |
| 26 | Type 2 muscle fiber atrophy (HP:0003554) | 3.18649585 |
| 27 | Hepatic necrosis (HP:0002605) | 3.16511420 |
| 28 | Abnormality of the neuromuscular junction (HP:0003398) | 3.15563104 |
| 29 | Fatigable weakness (HP:0003473) | 3.15563104 |
| 30 | Muscle fiber atrophy (HP:0100295) | 3.08682509 |
| 31 | Type 1 muscle fiber predominance (HP:0003803) | 2.99790716 |
| 32 | IgM deficiency (HP:0002850) | 2.98799137 |
| 33 | Increased intramyocellular lipid droplets (HP:0012240) | 2.98119623 |
| 34 | Aortic aneurysm (HP:0004942) | 2.91385617 |
| 35 | Increased IgM level (HP:0003496) | 2.89178745 |
| 36 | Abnormality of reticulocytes (HP:0004312) | 2.87446613 |
| 37 | Chronic otitis media (HP:0000389) | 2.85446066 |
| 38 | Increased muscle lipid content (HP:0009058) | 2.84968332 |
| 39 | 3-Methylglutaconic aciduria (HP:0003535) | 2.84264785 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.79693482 |
| 41 | Mitochondrial inheritance (HP:0001427) | 2.77675974 |
| 42 | Increased hepatocellular lipid droplets (HP:0006565) | 2.77193972 |
| 43 | Protrusio acetabuli (HP:0003179) | 2.75949258 |
| 44 | Aplasia of the musculature (HP:0100854) | 2.75044544 |
| 45 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.73402417 |
| 46 | Lipid accumulation in hepatocytes (HP:0006561) | 2.71131204 |
| 47 | Pancytopenia (HP:0001876) | 2.69481175 |
| 48 | Microcytic anemia (HP:0001935) | 2.69310199 |
| 49 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.65687143 |
| 50 | Malignant hyperthermia (HP:0002047) | 2.64935008 |
| 51 | Increased serum ferritin (HP:0003281) | 2.64176941 |
| 52 | Gowers sign (HP:0003391) | 2.57661338 |
| 53 | Fetal akinesia sequence (HP:0001989) | 2.53686392 |
| 54 | Increased CSF lactate (HP:0002490) | 2.53057627 |
| 55 | Acanthocytosis (HP:0001927) | 2.48718118 |
| 56 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47656858 |
| 57 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47656858 |
| 58 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47656858 |
| 59 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.46131973 |
| 60 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.46131973 |
| 61 | Abnormal protein glycosylation (HP:0012346) | 2.46131973 |
| 62 | Abnormal glycosylation (HP:0012345) | 2.46131973 |
| 63 | Microvesicular hepatic steatosis (HP:0001414) | 2.46052897 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.45672151 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.45647620 |
| 66 | Exertional dyspnea (HP:0002875) | 2.45296964 |
| 67 | Round ear (HP:0100830) | 2.43138181 |
| 68 | Ulnar deviation of the wrist (HP:0003049) | 2.43082828 |
| 69 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.42832126 |
| 70 | 11 pairs of ribs (HP:0000878) | 2.39444434 |
| 71 | Purpura (HP:0000979) | 2.39166936 |
| 72 | Oral leukoplakia (HP:0002745) | 2.38748425 |
| 73 | Stomatitis (HP:0010280) | 2.37838702 |
| 74 | Increased serum lactate (HP:0002151) | 2.37134218 |
| 75 | Recurrent abscess formation (HP:0002722) | 2.37128637 |
| 76 | Myelodysplasia (HP:0002863) | 2.36056789 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.35909620 |
| 78 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.35653489 |
| 79 | Orchitis (HP:0100796) | 2.34624225 |
| 80 | Poikilocytosis (HP:0004447) | 2.34096274 |
| 81 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.32009173 |
| 82 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.31395616 |
| 83 | Hypergammaglobulinemia (HP:0010702) | 2.29106718 |
| 84 | Aortic dissection (HP:0002647) | 2.28513829 |
| 85 | Meningitis (HP:0001287) | 2.28105393 |
| 86 | Distal lower limb muscle weakness (HP:0009053) | 2.27347486 |
| 87 | Acute necrotizing encephalopathy (HP:0006965) | 2.26984821 |
| 88 | Nonprogressive disorder (HP:0003680) | 2.26777657 |
| 89 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.26549056 |
| 90 | Lactic acidosis (HP:0003128) | 2.24483484 |
| 91 | Hyperbilirubinemia (HP:0002904) | 2.23159959 |
| 92 | Respiratory difficulties (HP:0002880) | 2.21749102 |
| 93 | Asymmetric septal hypertrophy (HP:0001670) | 2.21172329 |
| 94 | Neck muscle weakness (HP:0000467) | 2.20046169 |
| 95 | Chronic obstructive pulmonary disease (HP:0006510) | 2.20020647 |
| 96 | Obstructive lung disease (HP:0006536) | 2.20020647 |
| 97 | Recurrent fungal infections (HP:0002841) | 2.18558444 |
| 98 | Recurrent cutaneous fungal infections (HP:0011370) | 2.17709657 |
| 99 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.17709657 |
| 100 | Distal arthrogryposis (HP:0005684) | 2.16846194 |
| 101 | Gastrointestinal infarctions (HP:0005244) | 2.16181511 |
| 102 | Bulbar palsy (HP:0001283) | 2.16145902 |
| 103 | Generalized aminoaciduria (HP:0002909) | 2.15639179 |
| 104 | Exercise-induced myalgia (HP:0003738) | 2.14771778 |
| 105 | Eczematoid dermatitis (HP:0000976) | 2.14220278 |
| 106 | Spondylolisthesis (HP:0003302) | 2.13735135 |
| 107 | Birth length less than 3rd percentile (HP:0003561) | 2.12673800 |
| 108 | Hemoptysis (HP:0002105) | 2.12512311 |
| 109 | Panhypogammaglobulinemia (HP:0003139) | 2.12010913 |
| 110 | Abnormality of T cell physiology (HP:0011840) | 2.11515871 |
| 111 | Progressive muscle weakness (HP:0003323) | 2.08697335 |
| 112 | Renal Fanconi syndrome (HP:0001994) | 2.08600885 |
| 113 | Complement deficiency (HP:0004431) | 2.08238285 |
| 114 | Microretrognathia (HP:0000308) | 2.07617076 |
| 115 | Exercise intolerance (HP:0003546) | 2.07295968 |
| 116 | Vasculitis (HP:0002633) | 2.07109758 |
| 117 | Chest pain (HP:0100749) | 2.06896499 |
| 118 | Weak cry (HP:0001612) | 2.06656300 |
| 119 | Abnormality of iron homeostasis (HP:0011031) | 2.05778301 |
| 120 | Abnormality of T cell number (HP:0011839) | 2.02951636 |
| 121 | Increased variability in muscle fiber diameter (HP:0003557) | 2.02544165 |
| 122 | Joint stiffness (HP:0001387) | 2.02030017 |
| 123 | Neutropenia (HP:0001875) | 2.01159601 |
| 124 | Peritonitis (HP:0002586) | 2.01132216 |
| 125 | Optic neuritis (HP:0100653) | 1.99886996 |
| 126 | Retrobulbar optic neuritis (HP:0100654) | 1.99886996 |
| 127 | Abnormal pupillary function (HP:0007686) | 1.99390206 |
| 128 | Eosinophilia (HP:0001880) | 1.98766741 |
| 129 | Vascular tortuosity (HP:0004948) | 1.96005425 |
| 130 | Dysostosis multiplex (HP:0000943) | 1.95369494 |
| 131 | Abnormality of T cells (HP:0002843) | 1.95137117 |
| 132 | Hypoplasia of the thymus (HP:0000778) | 1.94529059 |
| 133 | Polycythemia (HP:0001901) | 1.94295055 |
| 134 | Granulocytopenia (HP:0001913) | 1.92315169 |
| 135 | Hyperlipoproteinemia (HP:0010980) | 1.91324949 |
| 136 | Encephalitis (HP:0002383) | 1.91255078 |
| 137 | Ragged-red muscle fibers (HP:0003200) | 1.91099306 |
| 138 | Agammaglobulinemia (HP:0004432) | 1.91017452 |
| 139 | Recurrent bacterial skin infections (HP:0005406) | 1.90850601 |
| 140 | Recurrent bronchitis (HP:0002837) | 1.88896589 |
| 141 | Nasal polyposis (HP:0100582) | 1.88810019 |
| 142 | Hepatosplenomegaly (HP:0001433) | 1.88415290 |
| 143 | Hematochezia (HP:0002573) | 1.87990678 |
| 144 | T lymphocytopenia (HP:0005403) | 1.87577994 |
| 145 | Severe visual impairment (HP:0001141) | 1.86111890 |
| 146 | Muscle fiber splitting (HP:0003555) | 1.85874177 |
| 147 | Hyporeflexia of lower limbs (HP:0002600) | 1.85500404 |
| 148 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.84790835 |
| 149 | Acute myeloid leukemia (HP:0004808) | 1.83928170 |
| 150 | Abnormality of complement system (HP:0005339) | 1.83491675 |
| 151 | Recurrent skin infections (HP:0001581) | 1.82707169 |
| 152 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.82347538 |
| 153 | Abnormality of B cell number (HP:0010975) | 1.82043875 |
| 154 | Rhabdomyolysis (HP:0003201) | 1.81164687 |
| 155 | IgG deficiency (HP:0004315) | 1.79978638 |
| 156 | Hypoproteinemia (HP:0003075) | 1.79298670 |
| 157 | Abnormality of alanine metabolism (HP:0010916) | 1.79194459 |
| 158 | Hyperalaninemia (HP:0003348) | 1.79194459 |
| 159 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.79194459 |
| 160 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78252989 |
| 161 | Acute encephalopathy (HP:0006846) | 1.77365594 |
| 162 | Chronic diarrhea (HP:0002028) | 1.77284302 |
| 163 | Premature rupture of membranes (HP:0001788) | 1.76803366 |
| 164 | Recurrent viral infections (HP:0004429) | 1.74981687 |
| 165 | Migraine (HP:0002076) | 1.74971683 |
| 166 | Esophageal neoplasm (HP:0100751) | 1.74611097 |
| 167 | Neoplasm of head and neck (HP:0012288) | 1.74611097 |
| 168 | Patchy hypopigmentation of hair (HP:0011365) | 1.73854805 |
| 169 | Albinism (HP:0001022) | 1.72079458 |
| 170 | Short middle phalanx of the 5th finger (HP:0004220) | 1.71436052 |
| 171 | Reticulocytosis (HP:0001923) | 1.70849126 |
| 172 | Easy fatigability (HP:0003388) | 1.70560767 |
| 173 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.69544992 |
| 174 | Spontaneous hematomas (HP:0007420) | 1.69459898 |
| 175 | Gingival bleeding (HP:0000225) | 1.69448780 |
| 176 | Abnormal spermatogenesis (HP:0008669) | 1.69221729 |
| 177 | Lymphoma (HP:0002665) | 1.68767041 |
| 178 | Acute lymphatic leukemia (HP:0006721) | 1.68740910 |
| 179 | Myositis (HP:0100614) | 1.67721960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 4.10127909 |
| 2 | NME2 | 3.84483391 |
| 3 | MUSK | 3.12053724 |
| 4 | TIE1 | 2.81053234 |
| 5 | KDR | 2.54561671 |
| 6 | PIM2 | 2.50526432 |
| 7 | MAP4K1 | 2.34128565 |
| 8 | TGFBR1 | 2.25254246 |
| 9 | KIT | 2.23750475 |
| 10 | WEE1 | 2.23227296 |
| 11 | TNIK | 2.22370403 |
| 12 | ACVR1B | 2.13626342 |
| 13 | TGFBR2 | 2.12316748 |
| 14 | TEC | 2.07427695 |
| 15 | LIMK1 | 2.07207971 |
| 16 | VRK1 | 1.92874872 |
| 17 | CDK19 | 1.90079679 |
| 18 | FES | 1.73811602 |
| 19 | MAP2K3 | 1.70875064 |
| 20 | CDK8 | 1.67149164 |
| 21 | BTK | 1.64778080 |
| 22 | DYRK3 | 1.63987271 |
| 23 | TESK2 | 1.62876976 |
| 24 | EIF2AK1 | 1.58104739 |
| 25 | VRK2 | 1.56298219 |
| 26 | RIPK4 | 1.52862734 |
| 27 | MKNK1 | 1.49823174 |
| 28 | TXK | 1.46456393 |
| 29 | MAP3K12 | 1.43293974 |
| 30 | MYLK | 1.41997183 |
| 31 | TBK1 | 1.37192360 |
| 32 | MAPKAPK5 | 1.35871589 |
| 33 | TESK1 | 1.32500474 |
| 34 | MOS | 1.30920713 |
| 35 | CSK | 1.29465813 |
| 36 | PRKG2 | 1.27220430 |
| 37 | MATK | 1.25741741 |
| 38 | IKBKE | 1.25549122 |
| 39 | EEF2K | 1.24103388 |
| 40 | RPS6KB2 | 1.23951668 |
| 41 | JAK3 | 1.22853833 |
| 42 | BCKDK | 1.19919840 |
| 43 | MKNK2 | 1.19087197 |
| 44 | PTK2B | 1.18788006 |
| 45 | JAK1 | 1.15389438 |
| 46 | ITK | 1.14910196 |
| 47 | FLT3 | 1.09164531 |
| 48 | ZAP70 | 1.08411099 |
| 49 | SCYL2 | 1.07464911 |
| 50 | TLK1 | 1.07147991 |
| 51 | CDK7 | 1.04548665 |
| 52 | LRRK2 | 1.03130079 |
| 53 | PIM1 | 1.02772730 |
| 54 | IKBKB | 1.01552261 |
| 55 | SRPK1 | 0.99950887 |
| 56 | IRAK4 | 0.99612651 |
| 57 | BRSK2 | 0.99600716 |
| 58 | EIF2AK3 | 0.97345868 |
| 59 | ABL2 | 0.97034717 |
| 60 | ADRBK2 | 0.95323839 |
| 61 | HCK | 0.94622177 |
| 62 | CDC7 | 0.94128550 |
| 63 | GRK6 | 0.90760669 |
| 64 | TYK2 | 0.87795113 |
| 65 | ATR | 0.84741210 |
| 66 | NEK2 | 0.84530348 |
| 67 | EPHB2 | 0.82794186 |
| 68 | DDR2 | 0.82028989 |
| 69 | EIF2AK2 | 0.82000934 |
| 70 | PRKD2 | 0.81765772 |
| 71 | RPS6KA4 | 0.81701900 |
| 72 | MAPKAPK3 | 0.81081472 |
| 73 | ROCK1 | 0.81070028 |
| 74 | DAPK3 | 0.80022498 |
| 75 | ILK | 0.79802379 |
| 76 | SYK | 0.79280979 |
| 77 | CAMK1 | 0.79121829 |
| 78 | BUB1 | 0.79085384 |
| 79 | BLK | 0.78631215 |
| 80 | MAP3K11 | 0.77921980 |
| 81 | CSF1R | 0.77532816 |
| 82 | PIK3CG | 0.77418571 |
| 83 | CCNB1 | 0.75991823 |
| 84 | ADRBK1 | 0.75815936 |
| 85 | MAP3K7 | 0.74801009 |
| 86 | LYN | 0.74683588 |
| 87 | PINK1 | 0.72964789 |
| 88 | OBSCN | 0.72494999 |
| 89 | MAPK12 | 0.72386825 |
| 90 | GRK5 | 0.72077825 |
| 91 | NUAK1 | 0.70478495 |
| 92 | PRKCQ | 0.70398953 |
| 93 | TAOK3 | 0.70134530 |
| 94 | TNK2 | 0.64270279 |
| 95 | GRK1 | 0.64234870 |
| 96 | PKN2 | 0.64189289 |
| 97 | ARAF | 0.63746710 |
| 98 | CDK4 | 0.63223525 |
| 99 | MAP3K6 | 0.62907198 |
| 100 | AURKB | 0.61355114 |
| 101 | ZAK | 0.59788213 |
| 102 | MAPK4 | 0.59582312 |
| 103 | STK24 | 0.58345332 |
| 104 | MAPK7 | 0.58221050 |
| 105 | EPHB1 | 0.57346629 |
| 106 | ABL1 | 0.56811932 |
| 107 | NLK | 0.56809359 |
| 108 | MAP4K2 | 0.55809684 |
| 109 | PASK | 0.55563648 |
| 110 | BMPR2 | 0.54829177 |
| 111 | MST4 | 0.54102836 |
| 112 | IRAK3 | 0.53130793 |
| 113 | MAP3K14 | 0.51203297 |
| 114 | IGF1R | 0.49738139 |
| 115 | MAPK11 | 0.48788316 |
| 116 | PAK4 | 0.47772518 |
| 117 | MAP3K13 | 0.46824933 |
| 118 | DAPK1 | 0.46274984 |
| 119 | RPS6KA6 | 0.45086494 |
| 120 | PRKD1 | 0.44510891 |
| 121 | TSSK6 | 0.44316098 |
| 122 | SIK3 | 0.43316504 |
| 123 | NEK9 | 0.43232532 |
| 124 | MAP3K3 | 0.43119707 |
| 125 | STK4 | 0.42637547 |
| 126 | FER | 0.41573924 |
| 127 | TTN | 0.41335167 |
| 128 | CSNK2A1 | 0.41080447 |
| 129 | MAP2K6 | 0.40881243 |
| 130 | ERN1 | 0.40836209 |
| 131 | GRK7 | 0.40554756 |
| 132 | LCK | 0.40321425 |
| 133 | PRKCD | 0.40202050 |
| 134 | STK10 | 0.39911687 |
| 135 | NME1 | 0.39779120 |
| 136 | INSRR | 0.39507036 |
| 137 | RPS6KA5 | 0.39405066 |
| 138 | TRPM7 | 0.39054432 |
| 139 | CSNK2A2 | 0.39002913 |
| 140 | TAOK2 | 0.37618643 |
| 141 | JAK2 | 0.37315533 |
| 142 | PHKG1 | 0.36336288 |
| 143 | PHKG2 | 0.36336288 |
| 144 | FGR | 0.35459072 |
| 145 | INSR | 0.34659200 |
| 146 | CDC42BPA | 0.34531918 |
| 147 | MAPKAPK2 | 0.31415178 |
| 148 | ROCK2 | 0.31381201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.83278870 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.80340542 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.54573186 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.53584484 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.22912561 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.18296305 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.76251760 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.71356632 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.71132688 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.65540902 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.61326895 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.37486708 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.26689859 |
| 14 | Proteasome_Homo sapiens_hsa03050 | 2.24133131 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 2.20627364 |
| 16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.05632704 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.91139744 |
| 18 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.84505734 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.72046866 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.71119353 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.67794726 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.66939256 |
| 23 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.65833146 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.58744622 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.58093905 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.57219965 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.55967446 |
| 28 | Purine metabolism_Homo sapiens_hsa00230 | 1.53865109 |
| 29 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.51601798 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.49230024 |
| 31 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.46426973 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.46217670 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.44989160 |
| 34 | Cell cycle_Homo sapiens_hsa04110 | 1.29606452 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.29425330 |
| 36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.27697450 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26731614 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.24073513 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.21134845 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20333931 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.16568243 |
| 42 | RNA transport_Homo sapiens_hsa03013 | 1.15512286 |
| 43 | Huntingtons disease_Homo sapiens_hsa05016 | 1.14610207 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12996715 |
| 45 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.12290812 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.11220032 |
| 47 | Measles_Homo sapiens_hsa05162 | 1.08808983 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.07889964 |
| 49 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.02908893 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.01264721 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.01158586 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 0.97603617 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92484513 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.91571684 |
| 55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89311481 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88164741 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.87812756 |
| 58 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.87094843 |
| 59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86763401 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.86160944 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85935963 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83343190 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.81327225 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81261260 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.80008914 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78912103 |
| 67 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78450353 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76032193 |
| 69 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75827040 |
| 70 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75432531 |
| 71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75432105 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73306208 |
| 73 | Leishmaniasis_Homo sapiens_hsa05140 | 0.73150854 |
| 74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.72998570 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71124138 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66913501 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66478409 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.64647659 |
| 79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64405334 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.64103342 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63840851 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60355831 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59335811 |
| 84 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58743515 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58110603 |
| 86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57948193 |
| 87 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57940206 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57816499 |
| 89 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57616209 |
| 90 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.54803220 |
| 91 | Malaria_Homo sapiens_hsa05144 | 0.54602285 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53592117 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52477219 |
| 94 | Hepatitis B_Homo sapiens_hsa05161 | 0.52369442 |
| 95 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51916028 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51130975 |
| 97 | Asthma_Homo sapiens_hsa05310 | 0.49613631 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.49369662 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48755891 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.48445428 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47874764 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46857619 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46834932 |
| 104 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44729236 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44463591 |
| 106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43796410 |
| 107 | Focal adhesion_Homo sapiens_hsa04510 | 0.43567386 |
| 108 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43483826 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42972975 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42488181 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42247612 |
| 112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41989618 |
| 113 | Shigellosis_Homo sapiens_hsa05131 | 0.41142668 |
| 114 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40030940 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39035393 |
| 116 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.38403809 |
| 117 | Influenza A_Homo sapiens_hsa05164 | 0.37959133 |
| 118 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.37377700 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.37367094 |
| 120 | Allograft rejection_Homo sapiens_hsa05330 | 0.36641120 |
| 121 | ABC transporters_Homo sapiens_hsa02010 | 0.36485121 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36167250 |
| 123 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36007363 |
| 124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35966418 |
| 125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34970717 |
| 126 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.33684001 |
| 127 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.33582844 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.33112437 |
| 129 | Pertussis_Homo sapiens_hsa05133 | 0.30853118 |
| 130 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.29550258 |
| 131 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.28300815 |
| 132 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27156990 |
| 133 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.26929241 |
| 134 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.26474633 |
| 135 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.22612028 |
| 136 | Carbon metabolism_Homo sapiens_hsa01200 | 0.22278920 |
| 137 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.20133860 |
| 138 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.19410014 |
| 139 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.19324143 |
| 140 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.19128472 |
| 141 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.15539951 |
| 142 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.15165824 |
| 143 | Viral myocarditis_Homo sapiens_hsa05416 | 0.14241298 |

